Over 30 million adults have opted to take a pass on the COVID-19 vaccines, including around 3 million people over 65 years-old. They are exercising their personal choice to remain unprotected against the virus through vaccination, choosing to accept the associated risks.
Pfizer/BioNTech and Moderna have both begun clinical trials with an omicron-specific vaccine. Sounds good in theory, given that the majority of infections in the United States are with the omicron variant. However, there are numerous reason why such a product will not provide any additional benefits beyond the vaccines that are already available.
A family member became seriously ill last year. After some initial tests, a malignancy was diagnosed. Surgery was scheduled, followed by chemotherapy. Everything proceeded mostly as planned, with no medical hiccups. We are both well-educated, with backgrounds in medicine, health economics and risk analysis, which should have prepared us to maneuver the requirements of our health insurance provider and ensure that copays and pre- authorizations were handled as necessary. We were gravely mistaken.
Surprisingly, a new study has found that if you’re perceived as more popular on a mobile dating app, there is a higher chance that other users will avoid connecting with you. This is one of the major findings of a study that sought to examine the effect of a dating app user’s popularity rating on their demand on the online dating platform.
The blood supply in the U.S. is now at its lowest level in over a decade. Many of the nation’s blood centers currently have only a one-day supply of some blood types in inventory. This is dangerous because blood transfusions are needed for many surgeries. Blood is also used in the treatment of diseases like sickle cell anemia and certain cancers – and is critical to help those who suffer injuries from accidents or disasters.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
An audio journey of how data and analytics save lives, save money and solve problems.
A number of startups and cloud service providers are starting to offer tools for monitoring, evaluating, and correcting problems with generative AI in the hope of eliminating errors, hallucinations, and other systemic problems associated with this technology.
Catastrophic weather events, wars in Ukraine and the Middle East, trade conflicts, global pandemics—the forces disrupting supply chains are multiplying at a rate few could have anticipated.
Tariffs could raise the cost of medical care and prescription drugs for people in the U.S.
New findings from a team of renowned researchers calls for transparency and rigorous oversight of the U.S. Medicare Advantage (MA) program, the United States' largest healthcare capitation program.
LONDON, Dec 30 (Reuters) - Chemicals factories founded or owned by some of Russia's wealthiest men are supplying ingredients to plants that manufacture explosives used by Moscow's military during the war in Ukraine, an analysis of railway and financial data shows.
During the holiday season, a late delivery can sometimes feel like the end of the world. You’ve been there: you order a highly anticipated gadget, new clothes, or a last-minute gift, only to find out that your delivery is delayed. While many blame shipping companies or delivery drivers, the true culprit often lies deeper in the supply chain — at the heart of it all: forecasting.
Billionaire investor Mark Cuban's question to Representative Matt Gaetz, a Florida Republican, on energy costs took off on social media on Saturday.
Florida lawmakers have banned wind turbines off its shores and near the coast, saying the bill is meant to protect wildlife and prevent noise.